Literature DB >> 9406980

Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells.

J Shi1, Y Xiang, J W Simpkins.   

Abstract

Deposition of beta-amyloid (A beta) is a characteristic feature of the pathology of Alzheimer's disease (AD). Since glucose metabolism and the consequential ATP production are depressed in the temporal and parietal regions of the cortex in patients with AD, we designed the present study to investigate the possible role of hypometabolism in the pathogenesis of AD. We incubated rat primary cortical astroglial cells for 2 h to 4 days in a media deprived of 95% of its glucose and assessed the expression and alternative splicing of the mRNA that encoding beta-amyloid precursor protein (APP) using RT-PCR. Hypoglycemia caused a time-dependent increase in APP mRNA expression, which reaches a peak level of 173.2% of control expression (P < 0.05) at 24 h of hypoglycemia. Noteworthy, hypoglycemia favors the alternative splicing that includes the exon 7 segment, which encodes a Kunitz-type serine protease inhibitor domain. This study demonstrates that hypoglycemia increases APP mRNA expression in astroglial cells and processing of APP mRNA to a form that may encourage A beta deposits in AD. These data suggest that the observed hypometabolism in AD may contribute to its deposition of A beta in affected brain regions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406980     DOI: 10.1016/s0006-8993(97)00827-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent.

Authors:  A Salehi; E J Dubelaar; M Mulder; D F Swaab
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

2.  Effect of general anesthetics on amyloid precursor protein and mRNA levels in the rat brain.

Authors:  Miklós Palotás; András Palotás; Annamária Bjelik; Magdolna Pákáski; Marietta Hugyecz; Zoltán Janka; János Kálmán
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

Review 3.  Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

Authors:  Hyoung-Gon Lee; Rudy J Castellani; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

4.  Amyloid [Formula: see text] (1-42) peptide impairs mitochondrial respiration in primary human brain microvascular endothelial cells: impact of dysglycemia and pre-senescence.

Authors:  Siva S V P Sakamuri; Venkata N Sure; Xiaoying Wang; Gregory Bix; Vivian A Fonseca; Ricardo Mostany; Prasad V G Katakam
Journal:  Geroscience       Date:  2022-08-17       Impact factor: 7.581

Review 5.  Iron: the Redox-active center of oxidative stress in Alzheimer disease.

Authors:  Rudy J Castellani; Paula I Moreira; Gang Liu; Jon Dobson; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Neurochem Res       Date:  2007-05-17       Impact factor: 3.996

Review 6.  Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.

Authors:  Elena A Kosenko; Lyudmila A Tikhonova; Carmina Montoliu; George E Barreto; Gjumrakch Aliev; Yury G Kaminsky
Journal:  Front Neurosci       Date:  2018-01-05       Impact factor: 4.677

7.  Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases.

Authors:  Monika Ray; Jianhua Ruan; Weixiong Zhang
Journal:  Genome Biol       Date:  2008-10-08       Impact factor: 13.583

Review 8.  Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.

Authors:  Yael Avramovich-Tirosh; Tamar Amit; Orit Bar-Am; Orly Weinreb; Moussa B H Youdim
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

Review 9.  The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence.

Authors:  Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Amparo Urios; Carmina Montoliu
Journal:  J Clin Med       Date:  2020-01-12       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.